Mydecine (MYCO.CN) (NLBIF) is quickly upping its fungi authority. The mycology-focused company has signed an agreement with Applied Pharmaceutical Innovation (API), a translational commercial drug institute at the University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences.  Mydecine is a fungi and mushroom cultivator/product development company offering unique research and expertise in their field. Their partnership … Continue reading Mydecine Announces Groundbreaking Partnership with Applied Pharmaceutical Innovation